{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:08:39Z","timestamp":1747156119675,"version":"3.40.5"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"China Natural Science Foundation","doi-asserted-by":"crossref","award":["31101846"],"award-info":[{"award-number":["31101846"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Special Fund for Agro-science Research in the Public Interest from the Ministry of Agriculture, China","award":["201503241"],"award-info":[{"award-number":["201503241"]}]},{"name":"Provincial Natural Science Research Project of Anhui Colleges","award":["KJ2013A203"],"award-info":[{"award-number":["KJ2013A203"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.biologicals.2015.06.005","type":"journal-article","created":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T21:47:15Z","timestamp":1436132835000},"page":"377-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The efficacy of chimeric vaccines constructed with PEP-1 and Ii-Key linking to a hybrid epitope from heterologous viruses"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0420-8939","authenticated-orcid":false,"given":"Xue-lan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-jie","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-shan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fa-zhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-lin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2015.06.005_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/ni.2225","article-title":"A\u00a0CD74-dependent MHC class I endolysosomal cross-presentation pathway","volume":"13","author":"Basha","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.biologicals.2015.06.005_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/imm.12210","article-title":"Virus-encoded ectopic CD74 enhances poxvirus vaccine efficacy","volume":"141","author":"Walline","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.biologicals.2015.06.005_bib3","first-page":"A18","article-title":"Study of T cell response to Ii-Key\/MHC class II epitope hybrids in human type 1 diabetes","volume":"57","author":"Beyan","year":"2008","journal-title":"Diabetes"},{"issue":"20","key":"10.1016\/j.biologicals.2015.06.005_bib4","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.2007.15.7842","article-title":"Results of the first phase I clinical trial of the novel Ii-Key hybrid preventive HER-2\/neu peptide (AE37) vaccine","volume":"26","author":"Holmes","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.biologicals.2015.06.005_bib5","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.4049\/jimmunol.1001877","article-title":"Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain","volume":"86","author":"Mikkelsen","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biologicals.2015.06.005_bib6","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1016\/j.vaccine.2012.02.031","article-title":"CD4+T-cell activation for immunotherapy of malignancies using Ii-Key\/MHC class II epitope hybrid vaccines","volume":"30","author":"Xu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2015.06.005_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-1-4939-0345-0_26","article-title":"Invariant chain-peptide fusion vaccine using HER-2\/neu","volume":"1139","author":"Perez","year":"2014","journal-title":"Methods Mol Biol"},{"issue":"9","key":"10.1016\/j.biologicals.2015.06.005_bib8","first-page":"1069","article-title":"Biological activity and therapeutic potential of homologs of an Ii peptide which regulates antigenic peptide binding to cell surface MHC II molecules","volume":"47","author":"Adams","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.biologicals.2015.06.005_bib9","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1158\/0008-5472.CAN-04-1350","article-title":"Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcome","volume":"64","author":"Chamuleau","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.biologicals.2015.06.005_bib10","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nbt1201-1173","article-title":"Peptide carrier for the delivery of biologically active proteins into mammalian cells","volume":"19","author":"Morris","year":"2001","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.biologicals.2015.06.005_bib11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.intimp.2014.09.008","article-title":"Down-regulation of MAPK\/NF-kappa KB signaling underlies anti-inflammatory response induced by transduced PEP-1\u2013Prx2 proteins in LPS-induced raw 264.7 and TPA-induced mouse ear edema model","volume":"23","author":"Jeong","year":"2014","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"10.1016\/j.biologicals.2015.06.005_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5483\/BMBRep.2015.48.3.123","article-title":"The effects of PEP-1\u2013FK506BP on dry eye disease in a rat model","volume":"48","author":"Kim","year":"2015","journal-title":"BMB Rep"},{"key":"10.1016\/j.biologicals.2015.06.005_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1016-8478(23)17550-9","article-title":"Transduction of familial amyotrophic lateral sclerosis-related mutant PEP-1\u2013SOD proteins into neuronal cells","volume":"25","author":"An","year":"2008","journal-title":"Mol Cells"},{"key":"10.1016\/j.biologicals.2015.06.005_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5483\/BMBRep.2012.45.9.083","article-title":"PEP-1\u2013p18 prevents neuronal cell death by inhibiting oxidative stress and Bax expression","volume":"45","author":"Kim","year":"2012","journal-title":"BMB Rep"},{"key":"10.1016\/j.biologicals.2015.06.005_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10059-009-0020-4","article-title":"In\u00a0vivo protein transduction: delivery of PEP-1\u2013SOD1 fusion protein into myocardium efficiently protects against ischemic insult","volume":"27","author":"Zhang","year":"2009","journal-title":"Mol Cells"},{"key":"10.1016\/j.biologicals.2015.06.005_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1089\/vim.2005.18.549","article-title":"Identification of neutralizing epitopes on the VP2 protein of infectious bursal disease virus by phage-displayed heptapeptide library screening and synthetic peptide mapping","volume":"18","author":"Wang","year":"2005","journal-title":"Viral Immunol"},{"key":"10.1016\/j.biologicals.2015.06.005_bib17","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1099\/0022-1317-69-8-2115","article-title":"Location of a neutralizing epitope for the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus","volume":"69","author":"Chammbers","year":"1988","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.biologicals.2015.06.005_bib18","first-page":"56","article-title":"An overview of western blotting for determining antibody specificities for immunohistochemistry","volume":"717","author":"Biji","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"2","key":"10.1016\/j.biologicals.2015.06.005_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.18632\/oncotarget.426","article-title":"Novel targeted therapies for mantle cell lymphoma","volume":"3","author":"Alinari","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.biologicals.2015.06.005_bib20","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1182\/blood-2011-09-381988","article-title":"Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20\/CD74 bispecific antibodies in mantle cell and other lymphomas","volume":"119","author":"Gupta","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.biologicals.2015.06.005_bib21","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.4049\/jimmunol.180.5.3339","article-title":"MHC class II-associated invariant chain linkage of antigen dramatically improves cell-mediated immunity induced by adenovirus vaccines","volume":"180","author":"Holst","year":"2008","journal-title":"Immunol"},{"key":"10.1016\/j.biologicals.2015.06.005_bib22","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1016\/j.vaccine.2009.05.054","article-title":"Ii-Key\/HPV16 E7 hybrid peptide immunotherapy for HPV16+ cancers","volume":"27","author":"Xu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2015.06.005_bib23","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.4049\/jimmunol.180.10.7019","article-title":"Enhancement of DNA vaccine potency through coadministration of CIITA DNA with DNA vaccines via gene gun","volume":"180","author":"Kim","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biologicals.2015.06.005_bib24","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/eji.201343671","article-title":"Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation","volume":"44","author":"Walchli","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.biologicals.2015.06.005_bib25","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1158\/1078-0432.CCR-10-0085","article-title":"Results from a phase I clinical study of the novel Ii-Key\/HER-2\/neus(776\u2013790) hybrid peptide vaccine in patients with prostate cancer","volume":"16","author":"Perez","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.biologicals.2015.06.005_bib26","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/ijc.22936","article-title":"Induction of potent CD4+ T cell-mediated antitumor responses by a helper HER-2\/neu peptide linked to the Ii-Key moiety of the invariant chain","volume":"121","author":"Voutsas","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.biologicals.2015.06.005_bib27","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s00262-003-0463-y","article-title":"Ii-Key\/HER-2\/neu MHC class-II antigenic epitope vaccine peptide for breast cancer","volume":"53","author":"Gillogly","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.biologicals.2015.06.005_bib28","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1742-4658.2008.06291.x","article-title":"Transduced human PEP-1-heat shock protein 27 efficiently protects against brain ischemic insult","volume":"275","author":"An","year":"2008","journal-title":"FEBS J"},{"issue":"7","key":"10.1016\/j.biologicals.2015.06.005_bib29","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.bbagen.2014.03.003","article-title":"Neuroprotective effect of PEP-1\u2013peroxiredoxin2 on CA1 regions in the hippocampus against ischemic insult","volume":"1840","author":"Jeong","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biologicals.2015.06.005_bib30","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1021\/jp209604m","article-title":"Molecular interactions between cell penetrating peptide Pep-1 and model cell membranes","volume":"116","author":"Ding","year":"2012","journal-title":"J\u00a0Phys Chem B"},{"key":"10.1016\/j.biologicals.2015.06.005_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2172-13-55","article-title":"Boosting immune response with the invariant chain segments via association with non-peptide binding region of major histocompatibility complex class II molecules","volume":"13","author":"Chen","year":"2012","journal-title":"BMC Immunol"},{"key":"10.1016\/j.biologicals.2015.06.005_bib32","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/01.cji.0000170362.45456.00","article-title":"Enhanced CD4+ T-cell response in DR4-transgenic mice to a hybrid peptide linking the Ii-Key segment of the invariant chain to the melanoma gp100(48\u201358) MHC class II epitope","volume":"28","author":"Kallinteris","year":"2005","journal-title":"J\u00a0Immunother"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105615000639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105615000639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T21:26:59Z","timestamp":1717968419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105615000639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1045105615000639"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2015.06.005","relation":{},"ISSN":["1045-1056"],"issn-type":[{"type":"print","value":"1045-1056"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of chimeric vaccines constructed with PEP-1 and Ii-Key linking to a hybrid epitope from heterologous viruses","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2015.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}